- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 705418, 9 pages
Enhanced Production of Acarbose and Concurrently Reduced Formation of Impurity C by Addition of Validamine in Fermentation of Actinoplanes utahensis ZJB-08196
1Institute of Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China
2Engineering Research Center of Bioconversion and Biopurification of Ministry of Education, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China
3Huadong Medicine Co., Ltd., Hangzhou, Zhejiang 310011, China
Received 4 September 2012; Revised 28 November 2012; Accepted 2 December 2012
Academic Editor: Jozef Anné
Copyright © 2013 Ya-Ping Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commercial production of acarbose is exclusively via done microbial fermentation with strains from the genera of Actinoplanes. The addition of C7N-aminocyclitols for enhanced production of acarbose and concurrently reduced formation of impurity C by cultivation of A. utahensis ZJB-08196 in 500-mL shake flasks was investigated, and validamine was found to be the most effective strategy. Under the optimal conditions of validamine addition, acarbose titer was increased from mg/L to mg/L, and impurity C concentration was concurrently decreased from mg/L to mg/L in batch fermentation after 168 h of cultivation. A further fed-batch experiment coupled with the addition of validamine (20 mg/L) in the fermentation medium prior to inoculation was designed to enhance the production of acarbose. When twice feedings of a mixture of 6 g/L glucose, 14 g/L maltose, and 9 g/L soybean flour were performed at 72 h and 96 h, acarbose titer reached mg/L and impurity C concentration was only mg/L at 168 h of cultivation. Acarbose titer and proportion of acarbose/impurity C increased by 85.6% and 152.9% when compared with control experiments. This work demonstrates for the first time that validamine addition is a simple and effective strategy for increasing acarbose production and reducing impurity C formation.
The -glycosidase inhibitor acarbose has been used in many countries in the therapy of diabetes type II, in order to enable patients to better control blood sugar contents while living with starch-containing diets. It is one of the latest successful products of bacterial secondary metabolism to be introduced into the pharmaceutical world market [1–5]. The structure of acarbose consists of an unsaturated cyclitol (valienol), a 4-amino-4,6-dideoxyglucose, and maltose (Scheme 1). The valienol and 4-amino-4,6-dideoxyglucose are linked via an amino bridge mimicking an N-glycosidic bond. This acarviosyl moiety is primarily responsible for the inhibitory effect on -glycosidases [6–8].
So far, commercial production of acarbose is exclusively via microbial fermentation with strains from the genera of Actinoplanes. Many experiments including producer strain mutagenesis and screening, media formula, fermentation conditions, and acarbose isolation and purification have been conducted in order to increase acarbose yield because of its high commercial value [1, 9–11]. However, major difficulties still exist in improving the yield of acarbose, leading to a high cost for its manufacture. Recently, Li et al. [12, 13] reported the medium optimization and scale-up strategy for acarbose fermentation by Actinoplanes sp. A56 and developed an optimized industrial fermentation processes for acarbose production, as a result about 5000 mg/L of acarbose was obtained. Our group has extensively studied the production of acarbose [14–18]. A high acarbose-producing mutant stain A. utahensis ZJB-08196 was isolated by mutagenesis and screening method . Fed-batch fermentation with A. utahensis ZJB-08196 at elevated osmolality via intermittently feeding of necessary components regarding acarbose formation afforded a peak acarbose titer of 4878 mg/L . By exogenous addition of S-adenosylmethionine (100 M) after 12 h inoculation in fed-batch fermentation, the maximal titer of acarbose was obtained at 6113 mg/L .
Besides acarbose, Actinoplanes sp. commonly produces an extensive series of acarviosyl containing acarbose-like components, including impurity A-H . These impurities differ in the number and type of glycosidic bonds which are attached to the acarviosyl core at the reducing and nonreducing ends. Impurity C is identical to that of acarbose except that the -1,4-D-glycosidic linkage of the maltose moiety in acarbose is replaced with a 1,1-linkage in impurity C (Scheme 1) . Due to its high structural similarity to acarbose, impurity C is hard to separate. The purified product still contains some contamination impurity C. Biosynthetic study demonstrated that impurity C was produced in excess during the later fermentation stage of Actinoplanes. It can be derived from acarbose. The ,-1,4-linkage in the maltose moiety of acarbose can be converted to an ,-1,1-linkage in the trehalose moiety of impurity C by glucosyltransferase . Approximately 2300 mg/L of acarbose was produced along with 600 mg/L of impurity C by cultivation of Actinoplanes sp. CKD485-16 . Actinoplanes sp. A56 produced approximately 5000 mg/L along with 530 mg/L of impurity C at the end of fermentation . A low proportion of acarbose/impurity C makes the purification of acarbose complicated. In order to simplify the separation process, one of the most promising methods is to increase the acarbose production and/or reduce the formation of impurity C by improving the proportion of acarbose/impurity C in the fermentation.
The C7N-aminocyclitols are structurally close to sugar moieties, which exhibit glycosidase and glucosyltransferase inhibitory effects . They may play an important role in the metabolic synthesis of acarbose and inhibit the generation of impurity C in fermentation process by Actinoplanes sp. In this work, the addition of validamine into the fermentation medium of A. utahensis ZJB-08196 was conducted to enhance production of acarbose and concurrently reduce the formation of impurity C in 500-mL shake flasks. The adding concentration and adding time of validamine on acarbose production were optimized. On the basis of above experiments, fed-batch cultivation of A. utahensis ZJB-08196 coupled with exogenous addition of validamine in fermentation medium was further investigated. The information obtained in this work would be helpful to industrial production of this important -glycosidase inhibitor, and validamine addition would be a novel and effective strategy for enhancing the acarbose fermentation.
2. Materials and Methods
Acarbose standard was purchased from Sigma. Maltose, glucose, sucrose, L-Tyr, monosodium glutamate, glycerol, K2HPO4·3H2O, MgSO4·7H2O, FeSO4·7H2O, KCl, FeCl3, CaCl2, CaCO3, and NaOH were of analytical reagent grade purity. Peptone, agar, and soybean meal were obtained from commercial sources. Validamycin A, validamycin B, validamycin D, and validamycin E were separated from crude validamycins by an anion-exchange column packed with resin A600 (Purolite Co. limited, China) according to the method as described previously . Valienamine and validamine were prepared by degradation of validamycin A with Stenotrophomonas maltophilia CCTCC M 204024 [23–26]. The purities of these compounds were more than 98%.
2.2. Microorganism and Cultivation Conditions
The mutant strain A. utahensis ZJB-08196, which was screened by our lab and previously deposited at the China Center for Type Culture Collection (Wuhan, China) as CCTCC M 209022, was used for acarbose production . This strain was stored as spore/mycelial suspensions in 15% (v/v) glycerol solution at −70°C until inoculation. It was spread over agar plates containing (g/L) sucrose 30.0, peptone 2.0, L-Tyr 1.0, K2HPO4·3H2O 1.0, KCl 0.5, MgSO4·7H2O 0.5, FeSO4 0.1, and agar 20.0, and the initial pH value was adjusted to 7.0. For inoculum, a colony of about 1 × 1 cm2 size from a freshly prepared agar plate was inoculated into a 500-mL shake flask containing 100 mL of seed medium and cultivated at 28°C and 200 rpm for 72 h. The seed medium consisted of (g/L) corn starch 15, soybean flour 40, glycerol 20, CaCO3 2.0, and K2HPO4 0.5, with pH unadjusted. Batch and fed-batch fermentations were carried out by inoculating 10% (v/v) of the seed culture into 500-mL shake flasks containing 50 mL of fermentation medium at 28°C and 200 rpm. The basal medium for acarbose fermentation consisted of (per L) maltose syrup (containing 11 g/L glucose and 160 g/L maltose) 270 mL, glucose 40.0 g, soybean flour 17.0 g, sodium glutamate 5.0 g, CaCO3 2.5 g, CaCl2 2.5 g, FeCl3 0.5 g, K2HPO4 1.0 g, and glycerol 5.0 g, and the initial pH value was adjusted to 7.0.
2.3. Effect of C7N-Aminocyclitols Addition on Acarbose Fermentation
Sterile-filtered aqueous solutions of C7N-aminocyclitols (validamycin A, validamycin B, validamycin D, validamycin E, valienamine, and validamine) were added into the fermentation medium, respectively, to investigate the effect of different C7N-aminocyclitols addition on acarbose fermentation. The adding concentration and adding time of validamine on acarbose production were optimized. On the basis of above experiments, an optimal feeding strategy, coupled with exogenous validamine addition (20 mg/L), was performed for maximum acarbose production.
2.4. Analytical Methods
Samples (5 mL) were centrifuged at 9,000 ×g for 15 min. The cell precipitates were dried at 80°C to a constant weight for determining dry cell weight (DCW) as the biomass. Acarbose titer and impurity C concentration in the supernatant were analyzed by using a Shimadzu CT0-10ASVP HPLC system according to the method as described previously . Maltose was measured according to known methodologies . Glucose in broth was measured with SBA-40E biosensor (Biology Institute of Shandong Academy of Sciences, China) after dilution (10–100X) with deionized water. Medium osmolality was assayed using an Osmometer, Model 3250, (Advanced, USA) in accordance with the manual.
2.5. Statistical Analysis
Each run of fermentation experiments was duplicated three times to ensure reliability and accuracy. Data are the average of three independent sample measurements. The error bars indicate the standard deviation (SD) from the mean of triplicates. Data were analyzed with Student’s -test. The difference between contrasting treatments was considered significant when is 0.05 in a two-tail analysis.
3. Results and Discussion
3.1. Time Courses of Acarbose Fermentation in Batch Culture of A. utahensis ZJB-08196
The time courses for acarbose accumulation, substrate consumption, cell growth, and impurity C formation in batch culture of A. utahensis ZJB-08196 were firstly investigated. Cultivations were performed in 500-mL shake flasks containing 50 mL of fermentation medium at 28°C and 200 rpm, and lasted for 216 h. The results were shown in Figure 1. Glucose, as the most easily utilizable carbon source, was almost exhausted in 144 h. Maltose in the fermentation medium was used as an energy source and as a precursor for acarbose. It was found that maltose was consumed slowly in the early stage of fermentation. After glucose was exhausted, maltose was consumed dramatically, accompanied by the rapid accumulation of acarbose. It was utilized not only as the carbon source for cell growth because of the exhaustion of glucose, but also as the direct precursor for the biosynthesis of acarbose. The pH value was observed to be increased slightly throughout the fermentation process (from 7 to 8). The medium osmolality decreased from 680 mOsm/kg to 389 mOsm/kg along with the consumption of substrate. Biomass increased for up to 6 days. Acarbose formation began at the early growth stages, as a mixed-growth-associated type of secondary metabolite in A. utahensis ZJB-08196, different from Actinoplanes sp. CKD485-16 [14, 20]. After 168 h of cultivation, acarbose titer reached the maximum value of mg/L. Impurity C, as a byproduct of the metabolism, began to accumulate from 72 h of cultivation with a remarkably increase after 144 h. It is from 168 h that the concentration of impurity C increased continuously along with the decrease of acarbose. It may be explained that an intracellular or cell-bound glucosyltransferase in A. utahensis ZJB-08196 converts the -1,4-glycosidic bond to -1,1 of the reducing end glucose moiety of acarbose. At the end of cultivation (216 h), the impurity C concentration reached approximately mg/L. According to the fermentation profiles, when the acarbose reached its highest titer (at 168 h), the concentration of impurity C was mg/L. It can be calculated that the proportion of acarbose/impurity C was only 12.32. As a byproduct, impurity C seems to be unavoidable. However, the higher concentration of impurity C produced in the fermentation added much pressure to downstream processing due to impurity C structural resemblance to acarbose. The US Food and Drug Administration and other regulatory agencies set strict limits on the content of impurity C (<1.5 percent). To satisfy the mandatory requirements, the purification methods utilize complex process in which a step using a combination of the cation exchanger and the anion exchanger is repeatedly performed and a chromatographic step using the cation exchanger is further conducted [28–30]. The higher proportion of acarbose/impurity C in fermentation would not only make the acarbose purification become simple, but also increased the product yield. It is very necessary to develop strategies to increase acarbose titer and/or decrease impurity C concentration to facilitate the downstream process by improving proportion of acarbose/impurity C.
3.2. Effect of Addition of C7N-Aminocyclitols on Acarbose Fermentation in Batch Culture
The C7N-aminocyclitols exhibited physiological roles in almost all aspects of microorganisms due to their glycosidase and glucosyltransferase inhibitory activity [8, 21]. They may affect the cell growth and metabolite accumulation in microorganism cultures. The spectrum of their biological activities is apparently broader than that was originally thought . Our group has developed a method for the production of validamycin A, validamycin B, validamycin D, and validamycin E with anion-exchange resin A600 and reported the protocol to prepare valienamine and validamine from validamycin A [22–26]. In this work, the effect of addition of C7N-aminocyclitols on acarbose fermentation was investigated. Validamycin A, validamycin B, validamycin D, validamycin E, valienamine, and validamine were added to the fermentation medium of A. utahensis ZJB-08196 at a final concentration of 80 mg/L prior to inoculation, respectively. The fermentations were carried out for 168 h in 500-mL shake flasks with 50 mL of fermentation medium at 28°C. The results were shown in Figure 2. No significant difference on acarbose titer and impurity C concentration was observed when validamycin B, validamycin D, and validamycin E were added to fermentation medium. Validamycin A, validamine, and valienamine can stimulate acarbose production and inhibit the impurity C formation. Biomass slightly increased after 168 h of cultivation (data no shown). These compounds might be involved with biosynthetic pathways of acarbose as activators and act as the inhibitor of glucosyltransferase. The highest acarbose titer of mg/L and lowest impurity C concentration of mg/L were obtained in the presence of validamine. Acarbose titer increased by 28.1%, and impurity C decreased by 65.7% compared with the levels in the absence of validamine. The proportion of acarbose/impurity C was improved from 12.32 to 45.14. The results indicate that validamine can be effectively used for enhanced production of acarbose and concurrently reduced formation of impurity C by cultivation of A. utahensis ZJB-08196. In the following experiments, the addition conditions were investigated about the positive effect of validamine on acarbose fermentation.
3.3. Effect of Adding Concentration of Validamine on Acarbose Fermentation in Batch Culture
Effect of different concentrations of validamine added in the fermentation medium on the formation of acarbose and impurity C was evaluated. Fermentations were carried out at 28°C and 200 rpm for 168 h with the exogenous addition of validamine in fermentation medium in the range from 0 to 160 mg/L prior to inoculation. The results were shown in Figure 3. DCW slightly increased by the addition of validamine. The acarbose titer increased with the increase of validamine concentration from 0 to 20 mg/L. The maximum acarbose titer of mg/L was obtained at 20 mg/L of validamine. Further increase of validamine amount led to a slight drop. The impurity C concentration decreased from mg/L to mg/L with an increase of validamine concentration from 0 to 20 mg/L. Impurity C reduced by about 62.9% at 20 mg/L of validamine compared with control experiment without addition of validamine. Further increase of validamine amount could not improve acarbose titer. No significant reduction in impurity C formation was found when validamine concentration was beyond 20 mg/L.
3.4. Effect of Adding Time of Validamine on Acarbose Fermentation in Batch Culture
Validamine was added at 0 h, 24 h, 48 h, 72 h, 96 h, and 120 h at final concentrations of 20 mg/L and 40 mg/L to study the effect of its adding time on acarbose fermentation. The results were shown in Figure 4. The addition time of validamine affected biomass. The biomass was increased by about 14% when validamine was added within 24 h after inoculation. The addition of validamine at 20 mg/L or 40 mg/L at all the fermentation time in the range from 0 to 120 h can not only promote acarbose yield, but also reduce the formation of impurity C. About 23.6–39.0% increase in acarbose titer and 12.4–62.9% reduction in impurity C concentration were obtained as compared with control experiments. The addition of validamine at the beginning of the fermentation was beneficial for the improvement of acarbose production and inhibition of impurity C formation. This finding indicated that the response of acarbose biosynthesis to the addition time was closely related to the cellular physiological state of A. utahensis ZJB-08196.
Time courses of acarbose formation, maltose and glucose consumption, cell growth, and impurity C accumulation during batch cultivation of A. utahensis ZJB-08196 in fermentation medium with the addition of validamine at 20 mg/L at the beginning of fermentation were shown in Figure 5. Acarbose titer reached the maximum value of mg/L at 168 h of cultivation. Impurity C began to accumulate after 72 h and reached mg/L at 168 h of cultivation. Its concentration remarkably increased after 168 h and increased continuously along with the decrease of acarbose. Therefore, the optimum fermentation period was 168 h. The medium osmolality decreased from 680 mOsm/kg to 345 mOsm/kg. The result indicated that the addition of validamine will led to a lower osmolality in the late stage of fermentation compared with the experiments without the addition of validamine (398 mOsm/kg). Our previous work revealed that A. utahensis ZJB-08196 had a broad osmolality optimum between 309 mOsm/kg and 719 mOsm/kg , which is quite different from those of Actinoplanes sp. SE50/110  and Actinoplanes sp. CKD485-16 . Therefore, the slight decrease of osmolality due to the addition of validamine in the fermentation of A. utahensis ZJB-08196 may have no effect on the acarbose production and impurity C formation.
3.5. Effect of Addition of Validamine on the Acarbose Fermentation in Fed-Batch Culture
Fed-batch culture is a common strategy in fermentation process to achieve good production . Effect of addition of validamine on the acarbose fermentation in fed-batch culture was also investigated. Fed-batch fermentations were carried at 28°C and 200 rpm for 216 h with the addition of validamine at a final concentration of 20 mg/L prior to inoculation. A proper feeding mode with the reasonable component constitution was developed for the intermittent fed-batch fermentation process. In our previous work, effect of each component in the feed of basal fermentation medium has been evaluated to examine what components are necessary for acarbose synthesis. The results showed that maltose, glucose, and soybean meal are essential feed components. Feeding of a mixture of 6 g/L glucose, 14 g/L maltose, and 9 g/L soybean flour is suitable for acarbose biosynthesis . We adopted the same feed composition in this work. Considering the acarbose and impurity C yield, as well as the length of fermentation period, effect of feeding time on the biosynthesis of acarbose and impurity C was examined at an interval of 24 h after inoculation. The maximum acarbose titer was obtained when twice feedings of a mixture (5 mL) of 6 g/L glucose, 14 g/L maltose, and 9 g/L soybean flour was performed at 72 h and 96 h. The time course of fermentation was shown in Figure 6. The validamine addition at the beginning of cultivation in fed-batch fermentation by A. utahensis ZJB-08196 accelerated the accumulation of acarbose greatly. A maximal acarbose titer of mg/L was obtained at 168 h, which is increased by more than 33.4% compared to the batch culture. Impurity C began to accumulate after 72 h and reached mg/L at 168 h of cultivation.
The comparison of the kinetic parameters of acarbose fermentation with different methods is shown in Table 1. The results showed that the addition of validamine played a very important role in A. utahensis ZJB-08196 fermentation. On one hand, the addition of validamine in the fermentation broth promoted the consumption rates of glucose and maltose. The specific consumption rates of glucose and maltose increased by 4.4% and 15.1% in batch fermentation compared with the control experiments in the absence of validamine. In fed-batch fermentation, the specific consumption rates of glucose and maltose increased by 47.8% and 71.5%. On the other hand, the addition of validamine in the fermentation increased the maximum acarbose titer, acabose productivity, and proportion of acarbose/impurity C greatly. Compared with control experiments, the maximum acarbose titer, acarbose productivity, and proportion of acarbose/impurity C increased by 39.0%, 39.0%, and 275.5% in batch fermentations, respectively. As for fed-batch fermentations, the maximum acarbose titer, acarbose productivity, and proportion of acarbose/impurity C increased by 85.6%, 85.6%, and 152.9%, respectively.
The regulative mechanism about validamine on acarbose production and impurity C formation by A. utahensis ZJB-08196 may be explained from two respects. On one hand, validamine is a glucosyltransferase inhibitor, which can inhibit the ,-1,4-linkage in the maltose moiety of acarbose to convert to an ,-1,1-linkage in the trehalose moiety of impurity C, thus reducing the formation of impurity C. On the other hand, validamine is involved with biosynthetic pathway of the acarbose as an activator. In order to discover the real mechanism of the effects of validamine on acarbose production and impurity C formation by A. utahensis ZJB-08196, we are working on the analysis of the transcription level of structural genes and global regulatory genes of acarbose and impurity C with the addition of validamine in fermentation medium by the cultivation of A. utahensis ZJB-08196.
The prevalence of diabetes, especially type II diabetes mellitus, is markedly increasing throughout the world . Facing such an increasingly worsening trend, the research and production of diabetes drugs including acarbose are becoming more and more critical to reduce the healthcare spending . Commercial production of validamine can be performed by microbial degradation of validamycin in one step fermentation with high yield . Validamycin is one of the largest yield antibiotics. Its fermentation concentration reaches 30,000 g/mL broth, and its cost is very low. This shows that validamine can be obtained with cheap price. In addition, the amount of validamine added to the fermentation medium is very low (20 mg/L). Therefore, the method of using validamine to enhance the production of acarbose and concurrently reduce the formation of impurity C is potential and hopeful in industrial application.
Acarbose, one of the most popular pharmaceuticals in the therapy of diabetes type II, is primarily manufactured using Actinoplanes sp. in a fermentation process. A higher acarbose titer and proportion of acarbose/impurity C in fermentation broth would facilitate the downstream process. The current study reveals for the first time that the addition of validamine is useful for the enhanced production of acarbose and concurrently reduced formation of impurity C by the cultivation of A. utahensis ZJB-08196, which would bring more convenience to product separation. Remarkable improvements on acarbose titer, acarbose productivity, and proportion of acarbose/impurity C were successfully achieved when 20 mg/L of validamine was added in the fermentation medium prior to inoculation both in batch and fed-batch cultures. The acarbose titer and acarbose productivity obtained in fed-batch culture in this work are the highest that have been reported for all the submerged fermentations of A. utahensis [10, 12–15, 19, 20, 27]. This simple and effective strategy would be of great value to acarbose production on commercial scale.
This work was financially supported by the National Natural Sciences Foundation of China (no. 20872132), China National Special Program for Key Science and Technology (no. 2008ZX09204-004), 973 Program (no. 2011CB710800), and Special Program for Key Science and Technology of Zhejiang (no. 2008C03004-1).
- U. F. Wehmeier and W. Piepersberg, “Biotechnology and molecular biology of the α-glucosidase inhibitor acarbose,” Applied Microbiology and Biotechnology, vol. 63, no. 6, pp. 613–625, 2004.
- H. Laube, “Acarbose: an update of its therapeutic use in diabetes treatment,” Clinical Drug Investigation, vol. 22, no. 3, pp. 141–156, 2002.
- J. A. Balfour and D. McTavish, “Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus,” Drugs, vol. 46, no. 6, pp. 1025–1054, 1993.
- J. L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso, “Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial,” The Lancet, vol. 359, no. 9323, pp. 2072–2077, 2002.
- S. Delorme and J. L. Chiasson, “Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus,” Current Opinion in Pharmacology, vol. 5, no. 2, pp. 184–189, 2005.
- C. S. Zhang, A. Stratmann, O. Block et al., “Biosynthesis of the C7-cyclitol moiety of acarbose in Actinoplanes species SE50/110. 7-O-phosphorylation of the initial cyclitol precursor leads to proposal of a new biosynthetic pathway,” Journal of Biological Chemistry, vol. 277, no. 25, pp. 22853–22862, 2002.
- T. Mahmud, I. Tornus, E. Egelkrout et al., “Biosynthetic studies on the α-glucosidase inhibitor acarbose in Actinoplanes sp.: 2-epi-5-epi-valiolone is the direct precursor of the valienamine moiety,” Journal of the American Chemical Society, vol. 121, no. 30, pp. 6973–6983, 1999.
- T. Mahmud, “The C7N aminocyclitol family of natural products,” Natural Product Reports, vol. 20, no. 1, pp. 137–166, 2003.
- J. F. Rodriguez, A. De Lucas, M. Carmona, and F. Cañas, “Application of ion exchange to purify acarbose from fermentation broths,” Biochemical Engineering Journal, vol. 40, no. 1, pp. 130–137, 2008.
- J. Beunink, M. Schedel, and U. Steiner, “Osmotically controlled fermentation process for the preparation of acarbose,” DE, 19637591, US, 6130072, 1997.
- S. M. Wei, G. Chen, W. Tian, D. S. Liu, Y. X. Zhang, and J. Y. He, “The feeding techniques in acarbose fermentation,” Chinese Journal of New Drugs, vol. 17, no. 11, pp. 923–926, 2008.
- K. T. Li, S. J. Wie, L. Huang, and X. Cheng, “An effective and simplified scale-up strategy for acarbose fermentation based on the carbon source control,” World Journal of Microbiology and Biotechnology, vol. 28, no. 2, pp. 749–753, 2012.
- K. T. Li, J. Zhou, S. J. Wei, and X. Cheng, “An optimized industrial fermentation processes for acarbose production by Actinoplanes sp. A56,” Bioresource Technology, vol. 118, pp. 580–583, 2012.
- Y. J. Wang, L. L. Liu, Z. H. Feng, Z. Q. Liu, and Y. G. Zheng, “Optimization of media composition and culture conditions for acarbose production by Actinoplanes utahensis ZJB-08196,” World Journal of Microbiology & Biotechnology, vol. 27, no. 12, pp. 2759–2766, 2011.
- Y. J. Wang, L. L. Liu, Y. S. Wang, Y. P. Xue, Y. G. Zheng, and Y. C. Shen, “Actinoplanes utahensis ZJB-08196 fed-batch fermentation at elevated osmolality for enhancing acarbose production,” Bioresource Technology, vol. 103, no. 1, pp. 337–342, 2012.
- Z. H. Feng, Y. S. Wang, and Y. G. Zheng, “A new microtiter plate-based screening method for microorganisms producing α-amylase inhibitors,” Biotechnology and Bioprocess Engineering, vol. 16, no. 5, pp. 894–900, 2011.
- Y. J. Wang, Y. G. Zheng, Y. P. Xue, Y. S. Wang, and Y. C. Shen, “Analysis and determination of anti-diabetes drug acarbose and its structural analogs,” Current Pharmaceutical Analysis, vol. 7, no. 1, pp. 12–20, 2011.
- Y. J. Wang, F. Z. Dong, L. Yu, and Y. G. Zheng, “Study on acarbose adsorption performance of cation exchanger SAC 001×7,” Journal of Chemical Engineering of Chinese Universities, vol. 26, no. 3, pp. 493–498, 2012.
- L. H. Sun, M. G. Li, Y. S. Wang, and Y. G. Zheng, “Significantly enhanced production of acarbose in fed-batch fermentation with the addition of S-adenosylmethionine,” Journal of Microbiology and Biotechnology, vol. 22, no. 6, pp. 826–831, 2012.
- B. T. Choi and C. S. Shin, “Reduced formation of byproduct component C in acarbose fermentation by Actinoplanes sp. CKD485-16,” Biotechnology Progress, vol. 19, no. 6, pp. 1677–1682, 2003.
- B. T. Choi and C. S. Shin, “Isolation and characterization of a novel intracellular glucosyltransferase from the acarbose producer Actinoplanes sp. CKD485-16,” Applied Microbiology and Biotechnology, vol. 65, no. 3, pp. 273–280, 2004.
- Y. G. Zheng, Y. P. Xue, Y. C. Shen, and Y. F. Wu, “Separation and preparation of validamycin A and validamycin B using anion-exchange resin,” Chemical Engineering Communications, vol. 193, no. 12, pp. 1581–1585, 2006.
- Y. G. Zheng, Y. P. Xue, and Y. C. Shen, “Production of valienamine by a newly isolated strain: Stenotrophomonas maltrophilia,” Enzyme and Microbial Technology, vol. 39, no. 5, pp. 1060–1065, 2006.
- Y. P. Xue, Y. G. Zheng, and Y. C. Shen, “Enhanced production of valienamine by Stenotrophomonas maltrophilia with fed-batch culture in a stirred tank bioreactor,” Process Biochemistry, vol. 42, no. 6, pp. 1033–1038, 2007.
- Y. G. Zheng, X. L. Chen, Y. P. Xue, Y. S. Wang, and Y. C. Shen, “Microbe method for producing valienamine and validamine,” WO2005098014 (A1), 2005.
- Y. P. Xue, Y. G. Zheng, X. L. Chen, and Y. C. Shen, “Quantitative determination of valienamine and validamine by thin-layer chromatography,” Journal of Chromatographic Science, vol. 45, no. 2, pp. 87–90, 2007.
- W. Jiang, Y. T. Yang, Y. M. Cai, M. J. Guo, and J. Chu, “Comprehensive effects of maltose concentration and medium osmotic pressure on acarbose in Actinoplanes sp. fermentation,” Chinese Journal of Pharmaceuticals, vol. 41, no. 3, pp. 178–182, 2010.
- K. Mihaljevic, J. Azaric, B. Bajic, V. Mrsa, and D. Kokanj, “Acarbose purification process,” US, 6734300, 2004.
- C. L. Lin, T. L. Huang, J. K. Chen, and C. S. Wu, “Purification process for manufacturing a high pure acarbose,” US, 07253278, 2007.
- V. Keri, L. Deak, and C. Szabo, “Purification of acarbose by chromatography with non-aromatic, strong acid cation exchanger,” WO2003014135-A, WO2003014135-A1, AU2002236918-A1, 2003.
- V. M. Ubiyvovk, V. M. Ananin, A. Y. Malyshev, H. A. Kang, and A. A. Sibirny, “Optimization of glutathione production in batch and fed-batch cultures by the wild-type and recombinant strains of the methylotrophic yeast Hansenula polymorpha DL-1,” BMC Biotechnology, vol. 11, article 8, 2011.
- G. Ning, J. Hong, Y. Bi et al., “Progress in diabetes research in China,” Journal of Diabetes, vol. 1, no. 3, pp. 163–172, 2009.
- W. Wang, W. P. McGreevey, C. Fu et al., “Type 2 diabetes mellitus in China: a preventable economic burden,” American Journal of Managed Care, vol. 15, no. 9, pp. 593–601, 2009.